pharmaphorum November 19, 2024
Private equity company Brookfield has reportedly moved closer to taking control of Grifols, after months of disruption at the Spanish pharma company.
A report in Spanish newspaper El Confidencial suggests that Brookfield is preparing to make a bid to take a 65% controlling stake in the drugmaker for €10.50 per share, worth around €7 billion ($7.4 billion).
That is below Grifols’ current share price of around €11, and well shy of its near-€15 share price at the start of the year, ahead of a campaign by hedge fund Gotham City Research, which claimed that the company had fraudulently manipulated its financial reporting and wiped around a third off its stock value.
Brookfield confirmed in September that it was considering a...
Today's Sponsors
Today's Sponsor